Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Interest & Investment Income (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Interest & Investment Income readings, the most recent being -$284.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 98.36% to -$284.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $198315.0, a 894.41% increase, with the full-year FY2025 number at $198315.0, up 894.41% from a year prior.
  • Interest & Investment Income hit -$284.0 in Q4 2025 for SBC Medical Group Holdings, down from $120384.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.3 million in Q1 2023 to a low of -$17340.0 in Q4 2024.
  • Median Interest & Investment Income over the past 3 years was $14666.5 (2024), compared with a mean of $194188.2.
  • Biggest five-year swings in Interest & Investment Income: crashed 4402.73% in 2024 and later soared 1414.26% in 2025.
  • SBC Medical Group Holdings' Interest & Investment Income stood at $403.0 in 2023, then crashed by 4402.73% to -$17340.0 in 2024, then surged by 98.36% to -$284.0 in 2025.
  • The last three reported values for Interest & Investment Income were -$284.0 (Q4 2025), $120384.0 (Q3 2025), and $22882.0 (Q2 2025) per Business Quant data.